Cite
HARVARD Citation
Stock, T. et al. (2017). Improved disease activity with fosdagrocorat (PF‐04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study. International journal of rheumatic diseases. pp. 960-970. [Online].